Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $380 Million. The most recent transaction as insider was on Oct 05, 2018, when has been sold 1,497 shares (Common Stock) at a price of $4.32 per share, resulting in proceeds of $6,467. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M

0% 3M change

0% 12M change

Total Value Held $380 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 05 2018	BUY Open market or private purchase	$6,467 $4.32 p/Share	1,497 Added 0.01%	17,503,912 Common Stock
Oct 04 2018	BUY Open market or private purchase	$8,765 $4.35 p/Share	2,015 Added 0.01%	17,502,415 Common Stock
Sep 27 2018	BUY Open market or private purchase	$30,358 $4.69 p/Share	6,473 Added 0.04%	17,500,400 Common Stock
Sep 26 2018	BUY Open market or private purchase	$21,442 $4.63 p/Share	4,631 Added 0.03%	17,493,927 Common Stock
Sep 25 2018	BUY Open market or private purchase	$42,762 $4.6 p/Share	9,296 Added 0.05%	17,489,296 Common Stock
Aug 17 2018	BUY Open market or private purchase	$3,910,000 $3.91 p/Share	1,000,000 Added 5.41%	17,480,000 Common Stock
Jul 31 2018	BUY Open market or private purchase	$2,758 $4.21 p/Share	655 Added 0.0%	16,480,000 Common Stock
Jul 30 2018	BUY Open market or private purchase	$9,372 $4.26 p/Share	2,200 Added 0.01%	16,479,345 Common Stock
Jul 27 2018	BUY Open market or private purchase	$75,952 $4.43 p/Share	17,145 Added 0.1%	16,477,145 Common Stock
Jul 26 2018	BUY Open market or private purchase	$18,283 $4.48 p/Share	4,081 Added 0.02%	16,460,000 Common Stock
Jul 25 2018	BUY Open market or private purchase	$33,418 $4.34 p/Share	7,700 Added 0.05%	16,455,919 Common Stock
Jul 18 2018	BUY Open market or private purchase	$10,875 $4.35 p/Share	2,500 Added 0.02%	16,448,219 Common Stock
Jul 17 2018	BUY Open market or private purchase	$41,792 $4.3 p/Share	9,719 Added 0.06%	16,445,719 Common Stock
Jul 16 2018	BUY Open market or private purchase	$75,828 $4.26 p/Share	17,800 Added 0.11%	16,436,000 Common Stock
Jul 02 2018	BUY Open market or private purchase	$16,264 $4.28 p/Share	3,800 Added 0.02%	16,418,200 Common Stock
Jun 28 2018	BUY Open market or private purchase	$59,328 $4.12 p/Share	14,400 Added 0.09%	16,414,400 Common Stock
May 23 2018	BUY Open market or private purchase	$1,155 $3.85 p/Share	300 Added 0.0%	16,400,000 Common Stock
May 22 2018	BUY Open market or private purchase	$29,033 $3.85 p/Share	7,541 Added 0.05%	16,399,700 Common Stock
May 21 2018	BUY Open market or private purchase	$158,939 $3.77 p/Share	42,159 Added 0.26%	16,392,159 Common Stock
May 17 2018	BUY Open market or private purchase	$106,091 $3.83 p/Share	27,700 Added 0.17%	16,350,000 Common Stock
May 16 2018	BUY Open market or private purchase	$36,000 $3.75 p/Share	9,600 Added 0.06%	16,322,300 Common Stock
May 15 2018	BUY Open market or private purchase	$325,377 $3.51 p/Share	92,700 Added 0.57%	16,312,700 Common Stock
Apr 23 2018	BUY Open market or private purchase	$25,808 $4.17 p/Share	6,189 Added 0.04%	16,220,000 Common Stock
Apr 20 2018	BUY Open market or private purchase	$2,154 $3.59 p/Share	600 Added 0.0%	16,213,811 Common Stock
Apr 19 2018	BUY Open market or private purchase	$47,163 $3.57 p/Share	13,211 Added 0.08%	16,213,211 Common Stock

Also insider at

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL